Activist fans, another lite day. Activist news and stories below. Send tips to @activiststocks, sign up for our daily newsletter, and ICYMI the latest newsletter, it’s here. News: Trian Fund and Nelson Peltz has dumped some of its Legg Mason shares. It lowered its stake by 5% and still owns 10.88% of the company. Kyle Bass is still at it with pharma patent challenges. Today, it’s Jazz Pharmaceuticals and its narcolepsy drug Xyrem. Recall Bass also announced challenges against Shire this week. Elliott Management finally books a win, getting Informatica sold. it’s going private for $48.75 a share. Note that Elliott…
Activist Stocks: Informatica, Legg Mason, Jazz Pharmaceuticals
Guest Post
If you are interested in contributing to ValueWalk on a regular or one time basis read this post http://www.valuewalk.com/guest-posts-hedge-fund-letters/ We do not accept any outside posts or even ads on penny stocks, ICOs, cryptos, forex, binary options and related products.